Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 557

1.

Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia.

Sonneveld ME, Natunen S, Sainio S, Koeleman CA, Holst S, Dekkers G, Koelewijn J, Partanen J, van der Schoot CE, Wuhrer M, Vidarsson G.

Br J Haematol. 2016 Mar 28. doi: 10.1111/bjh.14053. [Epub ahead of print]

PMID:
27017954
2.

Optimal digital filters for analyzing the mid-latency auditory P50 event-related potential in patients with Alzheimer's disease.

Liljander S, Holm A, Keski-Säntti P, Partanen JV.

J Neurosci Methods. 2016 Mar 22;266:50-67. doi: 10.1016/j.jneumeth.2016.03.013. [Epub ahead of print]

PMID:
27015794
3.

Conflicting HLA assignment by three different typing methods due to the apparent loss of heterozygosity in the MHC region.

Linjama T, Impola U, Niittyvuopio R, Kuittinen O, Kaare A, Rimpiläinen J, Volin L, Peräsaari J, Jaatinen T, Lauronen J, Saarinen T, Juvonen E, Partanen J, Koskela S.

HLA. 2016 May;87(5):350-5. doi: 10.1111/tan.12770. Epub 2016 Mar 10.

PMID:
26969202
4.

Ephaptic transmission from type ii afferents to static γ and β efferents causes complex repetitive discharge: An hypothesis.

Partanen JV.

Muscle Nerve. 2016 Apr;53(4):508-12. doi: 10.1002/mus.25056. Epub 2016 Feb 26.

PMID:
26802675
5.

Human stem cell decorated nanocellulose threads for biomedical applications.

Mertaniemi H, Escobedo-Lucea C, Sanz-Garcia A, Gandía C, Mäkitie A, Partanen J, Ikkala O, Yliperttula M.

Biomaterials. 2016 Mar;82:208-20. doi: 10.1016/j.biomaterials.2015.12.020. Epub 2015 Dec 21.

PMID:
26763735
6.

Differentiation and molecular heterogeneity of inhibitory and excitatory neurons associated with midbrain dopaminergic nuclei.

Lahti L, Haugas M, Tikker L, Airavaara M, Voutilainen MH, Anttila J, Kumar S, Inkinen C, Salminen M, Partanen J.

Development. 2016 Feb 1;143(3):516-29. doi: 10.1242/dev.129957. Epub 2015 Dec 30.

PMID:
26718003
7.

Truncated HSPB1 causes axonal neuropathy and impairs tolerance to unfolded protein stress.

Ylikallio E, Konovalova S, Dhungana Y, Hilander T, Junna N, Partanen JV, Toppila JP, Auranen M, Tyynismaa H.

BBA Clin. 2015 Mar 11;3:233-42. doi: 10.1016/j.bbacli.2015.03.002. eCollection 2015 Jun.

8.

Diversity and development of local inhibitory and excitatory neurons associated with dopaminergic nuclei.

Morello F, Partanen J.

FEBS Lett. 2015 Dec 21;589(24 Pt A):3693-701. doi: 10.1016/j.febslet.2015.10.001. Epub 2015 Oct 20. Review.

PMID:
26453835
9.

B-Cell Responses to Human Bocaviruses 1-4: New Insights from a Childhood Follow-Up Study.

Kantola K, Hedman L, Tanner L, Simell V, Mäkinen M, Partanen J, Sadeghi M, Veijola R, Knip M, Ilonen J, Hyöty H, Toppari J, Simell O, Hedman K, Söderlund-Venermo M.

PLoS One. 2015 Sep 29;10(9):e0139096. doi: 10.1371/journal.pone.0139096. eCollection 2015.

10.

Serine 62-Phosphorylated MYC Associates with Nuclear Lamins and Its Regulation by CIP2A Is Essential for Regenerative Proliferation.

Myant K, Qiao X, Halonen T, Come C, Laine A, Janghorban M, Partanen JI, Cassidy J, Ogg EL, Cammareri P, Laiterä T, Okkeri J, Klefström J, Sears RC, Sansom OJ, Westermarck J.

Cell Rep. 2015 Aug 11;12(6):1019-31. doi: 10.1016/j.celrep.2015.07.003. Epub 2015 Jul 30.

11.

Adapting Phonological Awareness Interventions for Children With Down Syndrome Based on the Behavioral Phenotype: A Promising Approach?

Lemons CJ, King SA, Davidson KA, Puranik CS, Fulmer D, Mrachko AA, Partanen J, Al Otaiba S, Fidler DJ.

Intellect Dev Disabil. 2015 Aug;53(4):271-88. doi: 10.1352/1934-9556-53.4.271.

PMID:
26214557
12.

Donor Haplotype B of NK KIR Receptor Reduces the Relapse Risk in HLA-Identical Sibling Hematopoietic Stem Cell Transplantation of AML Patients.

Impola U, Turpeinen H, Alakulppi N, Linjama T, Volin L, Niittyvuopio R, Partanen J, Koskela S.

Front Immunol. 2014 Aug 25;5:405. doi: 10.3389/fimmu.2014.00405. eCollection 2014.

13.

Internal development of vegetative buds of Norway spruce trees in relation to accumulated chilling and forcing temperatures.

Viherä-Aarnio A, Sutinen S, Partanen J, Häkkinen R.

Tree Physiol. 2014 May;34(5):547-56. doi: 10.1093/treephys/tpu038. Epub 2014 May 29.

PMID:
24876293
14.

Medium-high resolution electrochemical genotyping of HLA-DQ2/DQ8 for detection of predisposition to coeliac disease.

Joda H, Beni V, Alakulppi N, Partanen J, Lind K, Strömbom L, Latta D, Höth J, Katakis I, O'Sullivan CK.

Anal Bioanal Chem. 2014 May;406(12):2757-69. doi: 10.1007/s00216-014-7650-x. Epub 2014 Mar 15.

PMID:
24633503
15.

Interaction with intestinal epithelial cells promotes an immunosuppressive phenotype in Lactobacillus casei.

Tiittanen M, Keto J, Haiko J, Mättö J, Partanen J, Lähteenmäki K.

PLoS One. 2013 Nov 7;8(11):e78420. doi: 10.1371/journal.pone.0078420. eCollection 2013.

16.

Mechanisms regulating GABAergic neuron development.

Achim K, Salminen M, Partanen J.

Cell Mol Life Sci. 2014 Apr;71(8):1395-415. doi: 10.1007/s00018-013-1501-3. Epub 2013 Nov 7. Review.

PMID:
24196748
17.

The role of Tal2 and Tal1 in the differentiation of midbrain GABAergic neuron precursors.

Achim K, Peltopuro P, Lahti L, Tsai HH, Zachariah A, Astrand M, Salminen M, Rowitch D, Partanen J.

Biol Open. 2013 Aug 9;2(10):990-7. doi: 10.1242/bio.20135041. eCollection 2013.

18.

Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells.

Khanna A, Kauko O, Böckelman C, Laine A, Schreck I, Partanen JI, Szwajda A, Bormann S, Bilgen T, Helenius M, Pokharel YR, Pimanda J, Russel MR, Haglund C, Cole KA, Klefström J, Aittokallio T, Weiss C, Ristimäki A, Visakorpi T, Westermarck J.

Cancer Res. 2013 Nov 15;73(22):6757-69. doi: 10.1158/0008-5472.CAN-13-1002. Epub 2013 Sep 26.

19.

Breaking the epithelial polarity barrier in cancer: the strange case of LKB1/PAR-4.

Partanen JI, Tervonen TA, Klefström J.

Philos Trans R Soc Lond B Biol Sci. 2013 Sep 23;368(1629):20130111. doi: 10.1098/rstb.2013.0111. Print 2013. Review.

20.

Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.

Spierings E, Kim YH, Hendriks M, Borst E, Sergeant R, Canossi A, Oudshoorn M, Loiseau P, Dolstra H, Markiewicz M, Leffell MS, Pereira N, Kircher B, Turpeinen H, Eliaou JF, Gervais T, Laurin D, Enczmann J, Martinetti M, Thomson J, Oguz F, Santarone S, Partanen J, Siekiera U, Alessandrino EP, Kalayoglu S, Brand R, Goulmy E.

Biol Blood Marrow Transplant. 2013 Aug;19(8):1244-53. doi: 10.1016/j.bbmt.2013.06.001. Epub 2013 Jun 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk